K193299 is an FDA 510(k) clearance for the VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL). This device is classified as a System, Test, Automated, Antimicrobial Susceptibility, Short Incubation (Class II - Special Controls, product code LON).
Submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on September 28, 2020, 306 days after receiving the submission on November 27, 2019.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1645.